Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Fell Below 20 DMA | Bearish | 1.19% | |
| New Downtrend | Bearish | 1.19% | |
| Earnings Movers | Other | -4.49% | |
| Up 3 Days in a Row | Strength | -4.49% | |
| Up 4 Days in a Row | Strength | -4.49% | |
| Up 5 Days in a Row | Strength | -4.49% | |
| New Uptrend | Bullish | -2.58% | |
| Wide Bands | Range Expansion | -2.58% |
| Alert | Time |
|---|---|
| Rose Above 20 DMA | about 20 hours ago |
| Up 5% | about 20 hours ago |
| Up 3% | about 20 hours ago |
| Up 2% | about 20 hours ago |
| Up 1% | about 20 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.3099 |
| 52 Week Low | 1.8101 |
| Average Volume | 319,965 |
| 200-Day Moving Average | 4.04 |
| 50-Day Moving Average | 3.82 |
| 20-Day Moving Average | 3.36 |
| 10-Day Moving Average | 3.33 |
| Average True Range | 0.21 |
| RSI (14) | 46.24 |
| ADX | 24.76 |
| +DI | 21.24 |
| -DI | 21.40 |
| Chandelier Exit (Long, 3 ATRs) | 3.34 |
| Chandelier Exit (Short, 3 ATRs) | 3.70 |
| Upper Bollinger Bands | 3.78 |
| Lower Bollinger Band | 2.94 |
| Percent B (%b) | 0.55 |
| BandWidth | 25.21 |
| MACD Line | -0.10 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.0437 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.76 | ||||
| Resistance 3 (R3) | 3.79 | 3.69 | 3.70 | ||
| Resistance 2 (R2) | 3.69 | 3.60 | 3.68 | 3.68 | |
| Resistance 1 (R1) | 3.55 | 3.55 | 3.62 | 3.52 | 3.66 |
| Pivot Point | 3.45 | 3.45 | 3.49 | 3.44 | 3.45 |
| Support 1 (S1) | 3.31 | 3.36 | 3.38 | 3.28 | 3.14 |
| Support 2 (S2) | 3.21 | 3.31 | 3.20 | 3.12 | |
| Support 3 (S3) | 3.07 | 3.21 | 3.10 | ||
| Support 4 (S4) | 3.04 |
